Fund Holdings — SILVERARC CAPITAL MANAGEMENT, LLC

Total Portfolio Value:
$478.65M
Total Bought:
$152.37M
Total Sold:
$133.46M
Net Transaction:
+$18.91M
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Verona Pharma PlcADS516,014545,872+29,858$23.96M$34.66M7.24%+$10.69M
Merus N V680,845811,021+130,176$28.63M$34.14M7.13%+$5.51M
Nuvalent Inc400,014439,018+39,004$31.31M$31.14M6.50%-$177.9K
Akero Therapeutics Inc739,563719,992-19,571$20.57M$29.15M6.09%+$8.57M
Insmed Incorporated(INSM)372,230321,366-50,864$25.70M$24.52M5.12%-$1.18M
Kalvista Pharmaceuticals Inc612,1731,698,984+1,086,811$5.19M$19.61M4.10%+$14.42M
Veracyte, Inc.(VCYT)503,281633,832+130,551$19.93M$18.79M3.93%-$1.14M
Rhythm Pharmaceuticals, Inc.(RYTM)273,896337,605+63,709$15.33M$17.88M3.74%+$2.55M
Syndax Pharmaceuticals, Inc.(SNDX)1,230,4001,309,224+78,824$16.27M$16.08M3.36%-$182.1K
UroGen Pharma Ltd.(URGN)1,120,4731,381,158+260,685$11.93M$15.28M3.19%+$3.34M
Avidity Biosciences Inc543,651411,312-132,339$15.81M$12.14M2.54%-$3.67M
Soleno Therapeutics Inc0166,417+166,417$0$11.89M2.48%+$11.89M
Ascendis Pharma A/SADR(ASND)51,49175,751+24,260$7.09M$11.81M2.47%+$4.72M
Disc Medicine, Inc.(IRON)110,381236,471+126,090$7.00M$11.74M2.45%+$4.74M
ORIC Pharmaceuticals, Inc.(ORIC)1,178,3002,060,240+881,940$9.51M$11.50M2.40%+$1.99M
89bio Inc96,5111,510,498+1,413,987$754.7K$10.98M2.29%+$10.23M
Erasca, Inc.(ERAS)7,543,9017,367,996-175,905$18.94M$10.09M2.11%-$8.84M
Wave Life Sciences, Inc.SHS(WVE)608,8971,050,374+441,477$7.53M$8.49M1.77%+$955.0K
Neurocrine Biosciences, Inc.(NBIX)072,583+72,583$0$8.03M1.68%+$8.03M
Travere Therapeutics, Inc.(TVTX)277,365408,849+131,484$4.83M$7.33M1.53%+$2.49M
Gossamer Bio, Inc.(GOSS)6,171,8476,320,684+148,837$5.58M$6.95M1.45%+$1.37M
Gilead Sciences, Inc.(GILD)10,00062,029+52,029$923.7K$6.95M1.45%+$6.03M
Helix Acquisition Corp IiCL A513,369613,393+100,024$5.39M$6.93M1.45%+$1.54M
Elutia Inc.CL A(ELUT)1,782,2712,670,056+887,785$6.67M$6.76M1.41%+$89.5K
Praxis Precision Medicines, Inc.(PRAX)72,516166,074+93,558$5.58M$6.29M1.31%+$708.4K
Mineralys Therapeutics, Inc.(MLYS)0338,354+338,354$0$5.37M1.12%+$5.37M
Compugen Ltd.(CGEN)1,624,3772,895,430+1,271,053$2.49M$4.23M0.88%+$1.74M
Tarsus Pharmaceuticals, Inc.(TARS)65,95581,331+15,376$3.65M$4.18M0.87%+$526.0K
Alkermes plcSHS(ALKS)0124,871+124,871$0$4.12M0.86%+$4.12M
Ocular Therapeutix, Inc.(OCUL)0551,570+551,570$0$4.04M0.84%+$4.04M
BridgeBio Pharma, Inc.(BBIO)0111,000+111,000$0$3.84M0.80%+$3.84M
Kura Oncology, Inc.(KURA)0581,369+581,369$0$3.84M0.80%+$3.84M
Celldex Therapeutics, Inc.(CLDX)264,560205,962-58,598$6.69M$3.74M0.78%-$2.95M
Dianthus Therapeutics, Inc.(DNTH)0190,334+190,334$0$3.45M0.72%+$3.45M
Madrigal Pharmaceuticals, Inc.(MDGL)010,344+10,344$0$3.43M0.72%+$3.43M
Cerus Corporation(CERS)1,587,2282,456,537+869,309$2.44M$3.41M0.71%+$970.3K
TELA Bio, Inc.(TELA)3,065,6492,771,288-294,361$9.26M$3.38M0.71%-$5.88M
Centessa Pharmaceuticals PlcADS598,952232,758-366,194$10.03M$3.35M0.70%-$6.69M
Trevi Therapeutics, Inc.(TRVI)734,234530,000-204,234$3.03M$3.33M0.70%+$308.7K
Blueprint Medicines Corp037,345+37,345$0$3.31M0.69%+$3.31M
Structure Therapeutics IncADS152,395188,069+35,674$4.13M$3.26M0.68%-$877.5K
Benitec Biopharma Inc.(BNTC)0250,000+250,000$0$3.25M0.68%+$3.25M
Liquidia Corporation(LQDA)0214,057+214,057$0$3.16M0.66%+$3.16M
PTC Therapeutics, Inc.(PTCT)060,389+60,389$0$3.08M0.64%+$3.08M
Metsera Inc0112,759+112,759$0$3.07M0.64%+$3.07M
Biodesix, Inc.(BDSX)4,332,2814,098,406-233,875$6.63M$2.56M0.54%-$4.07M
Delcath Systems, Inc.(DCTH)155,325191,470+36,145$1.87M$2.44M0.51%+$567.3K
uniQure N.V.SHS(QURE)100,000203,400+103,400$1.77M$2.16M0.45%+$390.0K
Kiniksa Pharmaceuticals International, plcCL A(KNSA)088,215+88,215$0$1.96M0.41%+$1.96M
Solid Biosciences Inc0452,239+452,239$0$1.67M0.35%+$1.67M
Compass Therapeutics, Inc.(CMPX)0874,869+874,869$0$1.66M0.35%+$1.66M
C4 Therapeutics, Inc.(CCCC)1,221,131882,300-338,831$4.40M$1.41M0.29%-$2.98M
KALA BIO, Inc.(KALA)231,070246,079+15,009$1.60M$1.41M0.29%-$193.6K
Unicycive Therapeutics Inc2,486,7092,413,489-73,220$1.97M$1.39M0.29%-$587.4K
ABIVAX Société AnonymeADS(ABVX)285,120210,901-74,219$2.09M$1.32M0.28%-$768.9K
Kodiak Sciences Inc.(KOD)1,000,000441,807-558,193$9.95M$1.24M0.26%-$8.71M
Sionna Therapeutics, Inc.(SION)0114,138+114,138$0$1.19M0.25%+$1.19M
InflaRx N.V.(IFRX)01,161,567+1,161,567$0$1.18M0.25%+$1.18M
Mersana Therapeutics Inc03,088,505+3,088,505$0$1.06M0.22%+$1.06M
Modular Med Inc1,272,015958,881-313,134$1.74M$1.05M0.22%-$697.5K
Radiopharm Theranostics LimitedADS(RADX)187,406187,4060$841.5K$901.4K0.19%+$60.0K
Aardvark Therapeutics Inc0119,496+119,496$0$897.4K0.19%+$897.4K
Xenon Pharmaceuticals Inc.(XENE)010,121+10,121$0$339.6K0.07%+$339.6K
Avadel Pharmaceuticals Plc039,366+39,366$0$308.2K0.06%+$308.2K
Fractyl Health, Inc.(GUTS)176,922237,448+60,526$364.5K$282.6K0.06%-$81.9K
Vaxart, Inc.(VXRT)1,077,782683,825-393,957$713.6K$278.3K0.06%-$435.3K
Rocket Pharmaceuticals, Inc.W EXP 09 02 202(RCKT)104,828104,8280$3.6K$4.9K0.00%+$1.3K
BioAge Labs, Inc.(BIOA)39,9740-39,974$231.4K$0—-$231.4K
Cogent Biosciences, Inc.(COGT)921,1370-921,137$7.18M$0—-$7.18M
EyePoint, Inc.(EYPT)121,2740-121,274$903.5K$0—-$903.5K
Geron Corporation(GERN)920,0220-920,022$3.26M$0—-$3.26M
Incyte Corporation(INCY)49,0000-49,000$3.38M$0—-$3.38M
Intra-Cellular Therapies Inc179,0850-179,085$14.96M$0—-$14.96M
Karyopharm Therapeutics Inc.(KPTI)595,9900-595,990$403.1K$0—-$403.1K
Olema Oncology, Inc.(OLMA)233,2810-233,281$1.36M$0—-$1.36M
Pliant Therapeutics, Inc.(PLRX)1,315,6010-1,315,601$17.33M$0—-$17.33M
Poseida Therapeutics Inc1,012,3070-1,012,307$9.72M$0—-$9.72M
Scholar Rock Holding Corporation(SRRK)183,2430-183,243$7.92M$0—-$7.92M
Ultragenyx Pharmaceutical Inc.(RARE)124,3880-124,388$5.23M$0—-$5.23M
Vaxcyte, Inc.(PCVX)40,7880-40,788$3.34M$0—-$3.34M
Viridian Therapeutics, Inc.(VRDN)100,0000-100,000$1.92M$0—-$1.92M
Page 1 of 1
SILVERARC CAPITAL MANAGEMENT, LLC — 13F Holdings — Q1 2025 | TickerTrail